Citation: Maw. Verhoeven et S. Tuinier, THE SEROTONIN SYNDROME - 4 CASE-REPORTS AND A CONCISE REVIEW OF THE LITERATURE, The European journal of psychiatry, 12(1), 1998, pp. 12-18
Citation: Wma. Verhoeven et S. Tuinier, NEUROPSYCHIATRIC CONSULTATION IN MENTALLY-RETARDED PATIENTS - A CLINICAL REPORT, European psychiatry, 12(5), 1997, pp. 242-248
Citation: Wma. Verhoeven et al., SEROTONERGIC VARIABLES AND RESPONSE TO RISPERIDONE IN SCHIZOPHRENIA, Nordic journal of psychiatry, 51(2), 1997, pp. 97-97
Citation: Wma. Verhoeven et S. Tuinier, THE EFFECT OF BUSPIRONE ON CHALLENGING BEHAVIOR IN MENTALLY-RETARDED PATIENTS - AN OPEN PROSPECTIVE MULTIPLE-CASE STUDY, JIDR. Journal of intellectual disability research, 40, 1996, pp. 502-508
Citation: S. Tuinier et al., SEROTONIN AND DISRUPTIVE BEHAVIOR - A CRITICAL-EVALUATION OF THE CLINICAL-DATA, Human psychopharmacology, 11(6), 1996, pp. 469-482
Citation: S. Tuinier et Wma. Verhoeven, SELF-INJURY - PROGRESS IN THE UNDERSTANDING OF AN INTRACTABLE BEHAVIOR, Biological psychiatry, 39(7), 1996, pp. 76-76
Citation: S. Tuinier et Wma. Verhoeven, DIMENSIONAL CLASSIFICATION AND BEHAVIORAL PHARMACOLOGY OF PERSONALITY-DISORDERS - A REVIEW AND HYPOTHESIS, European neuropsychopharmacology, 5(2), 1995, pp. 135-146
Citation: S. Tuinier et al., CEREBROSPINAL-FLUID 5-HYDROXYINDOLACETIC ACID AND AGGRESSION - A CRITICAL REAPPRAISAL OF THE CLINICAL-DATA, International clinical psychopharmacology, 10(3), 1995, pp. 147-156
Authors:
TUINIER S
VERHOEVEN WMA
VANDENBERG YWMM
DEWITTEVANDERSCHOOT EPPM
PEPPLINKHUIZEN L
Citation: S. Tuinier et al., MODULATION OF SEROTONIN METABOLISM IN SELF-INJURIOUS-BEHAVIOR - AN OPEN STUDY WITH THE HT1 AGONIST ELTOPRAZINE IN MENTAL-RETARDATION, The European journal of psychiatry, 9(4), 1995, pp. 226-237
Citation: Maw. Verhoeven et S. Tuinier, SYMPTOMATOLOGY AND PATHOPHYSIOLOGY OF PSYCHOTIC DISORDERS IN PARKINSONS-DISEASE, The European journal of psychiatry, 9(1), 1995, pp. 37-46
Citation: S. Tuinier et Wma. Verhoeven, PSYCHIATRY AND MENTAL-RETARDATION - TOWARDS A BEHAVIORAL PHARMACOLOGICAL CONCEPT, JIDR. Journal of intellectual disability research, 37, 1993, pp. 16-25